Febuxostat: A Novel Non-Purine Selective Inhibitor of Xanthine Oxidase for the Treatment of Hyperuricemia in Gout
Publisher： Bentham Science Publishers
E-ISSN： 2212-2710|1|1|69-75
ISSN： 1872-213X
Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.1, Iss.1, 2007-02, pp. : 69-75
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
